Using an existing clinical dataset, UALCAN,49 we found reduced expression of Mfn1 in tumors, e.g., pheochromocytoma and paraganglioma, and thymoma, compared to normal tissues (Figure 6G). This evidence concerns the gene MFN1 and hereditary pheochromocytoma-paraganglioma.